Edmond De Rothschild Holding S.A. Bluebird Bio, Inc. Transaction History

Edmond De Rothschild Holding S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $59,702 - $82,324	-2,171 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$34.44 - $43.75 $17,047 - $21,656	-495 Reduced 18.57%	2,171 $117,000
Q2 2020 Aug 07, 2020	BUY	$27.12 - $45.97 $5,396 - $9,148	199 Added 8.07%	2,666 $163,000
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $2,145 - $5,207	-82 Reduced 3.22%	2,467 $113,000
Q4 2019 Feb 14, 2020	SELL	$46.96 - $61.67 $94,060 - $123,525	-2,003 Reduced 44.0%	2,549 $224,000
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $3,508 - $5,492	59 Added 1.31%	4,552 $418,000
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $76,825 - $106,577	1,013 Added 29.11%	4,493 $572,000
Q1 2019 May 13, 2019	BUY	$64.44 - $104.11 $224,251 - $362,302	3,480 New	3,480 $548,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.